BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31696196)

  • 1. Mitochondria-targeted cationic liposomes modified with alkyltriphenylphosphonium bromides loaded with hydrophilic drugs: preparation, cytotoxicity and colocalization assay.
    Kuznetsova DA; Gaynanova GA; Vasileva LA; Sibgatullina GV; Samigullin DV; Sapunova AS; Voloshina AD; Galkina IV; Petrov KA; Zakharova LY
    J Mater Chem B; 2019 Dec; 7(46):7351-7362. PubMed ID: 31696196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hybrid liposomal formulations based on imidazolium-containing amphiphiles for drug encapsulation.
    Kuznetsova DA; Gabdrakhmanov DR; Lukashenko SS; Ahtamyanova LR; Nizameev IR; Kadirov MK; Zakharova LY
    Colloids Surf B Biointerfaces; 2019 Jun; 178():352-357. PubMed ID: 30901595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases.
    Vasileva L; Gaynanova G; Kuznetsova D; Valeeva F; Lyubina A; Amerhanova S; Voloshina A; Sibgatullina G; Samigullin D; Petrov K; Zakharova L
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling systems based on amphiphilic alkyltriphenylphosphonium bromides: elucidation of the role of head group.
    Gainanova GA; Vagapova GI; Syakaev VV; Ibragimova AR; Valeeva FG; Tudriy EV; Galkina IV; Kataeva ON; Zakharova LY; Latypov SK; Konovalov AI
    J Colloid Interface Sci; 2012 Feb; 367(1):327-36. PubMed ID: 22134214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobized triphenyl phosphonium derivatives for the preparation of mitochondriotropic liposomes: choice of hydrophobic anchor influences cytotoxicity but not mitochondriotropic effect.
    Benien P; Solomon MA; Nguyen P; Sheehan EM; Mehanna AS; D'Souza GG
    J Liposome Res; 2016; 26(1):21-7. PubMed ID: 25811811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells.
    Wang L; MacDonald RC
    J Liposome Res; 2011 Dec; 21(4):306-14. PubMed ID: 21457078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes.
    Feng Y; Qin G; Chang S; Jing Z; Zhang Y; Wang Y
    Int J Nanomedicine; 2021; 16():3073-3089. PubMed ID: 33953556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
    Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
    J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
    Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
    Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model.
    Pashirova TN; Zueva IV; Petrov KA; Lukashenko SS; Nizameev IR; Kulik NV; Voloshina AD; Almasy L; Kadirov MK; Masson P; Souto EB; Zakharova LY; Sinyashin OG
    Colloids Surf B Biointerfaces; 2018 Nov; 171():358-367. PubMed ID: 30059851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
    Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
    Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the interactions of tiny amounts of common ionic surfactants with unsaturated phosphocholine lipid model membranes.
    Sęk A; Perczyk P; Szcześ A; Machatschek R; Wydro P
    Chem Phys Lipids; 2022 Oct; 248():105236. PubMed ID: 36007625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.
    Ivanova EA; Maslov MA; Kabilova TO; Puchkov PA; Alekseeva AS; Boldyrev IA; Vlassov VV; Serebrennikova GA; Morozova NG; Zenkova MA
    Org Biomol Chem; 2013 Nov; 11(41):7164-78. PubMed ID: 24057052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and inclusion into liposomes of a new cationic pyrenyl amphiphile.
    Petaccia M; Giansanti L; Leonelli F; Bella A; Gradella Villalva D; Mancini G
    Chem Phys Lipids; 2016 Oct; 200():83-93. PubMed ID: 27521791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of three-component hybrid liposomes containing cationic lipids without drugs on the growth of human renal tumor cells in vitro.
    Umebayashi M; Matsumoto Y; Ueoka R
    Biol Pharm Bull; 2008 Sep; 31(9):1816-7. PubMed ID: 18758085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niosomes from glucuronic acid-based surfactant as new carriers for cancer therapy: preparation, characterization and biological properties.
    Tavano L; Aiello R; Ioele G; Picci N; Muzzalupo R
    Colloids Surf B Biointerfaces; 2014 Jun; 118():7-13. PubMed ID: 24709252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.